Evidence map›Paper›PMID 33446567›Full record

ArticleGenes & development2021

An interplay of NOX1-derived ROS and oxygen determines the spermatogonial stem cell self-renewal efficiency under hypoxia.

Hiroko Morimoto, Takuya Yamamoto, Takehiro Miyazaki, Narumi Ogonuki, Atsuo Ogura, Takashi Tanaka, Mito Kanatsu-Shinohara, Chihiro Yabe-Nishimura, Hongliang Zhang, Yves Pommier and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. The ChickenGenes · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Editorial: Mammalian spermatogenesis: genetic and environmental factors.Frontiers in cell and developmental biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Hiroko MorimotoDepartment of Molecular Genetics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Takuya YamamotoDepartment of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.ORCID 0000-0002-0022-3947
Takehiro MiyazakiDepartment of Molecular Genetics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Narumi OgonukiBioresource Engineering Division, RIKEN BioResource Research Center, Ibaraki 305-0074, Japan.
Atsuo OguraBioresource Engineering Division, RIKEN BioResource Research Center, Ibaraki 305-0074, Japan.
Takashi TanakaDepartment of Molecular Genetics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Mito Kanatsu-ShinoharaDepartment of Molecular Genetics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Chihiro Yabe-NishimuraDepartment of Pharmacology, Kyoto Prefectural University of Medicine, Kyoto 606-8566, Japan.
Hongliang ZhangDevelopmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland 20892, USA.
Yves PommierDevelopmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland 20892, USA.
Andreas TrumppDivision of Stem Cells and Cancer, Deutsches Krebsforshungszentrum (DKFZ), 69120 Heidelberg, Germany.
Takashi ShinoharaDepartment of Molecular Genetics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Kyoto University · JPNational Cancer Institute · USRIKEN BioResource Research Center · JPHeidelberg University · DEKyoto Prefectural University · JP

Funding

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer DrugsZIABC006150 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 2009 to 2025
$23.0M
6 · The paper itself

Abstract

Reactive oxygen species (ROS) produced by NADPH1 oxidase 1 (NOX1) are thought to drive spermatogonial stem cell (SSC) self-renewal through feed-forward production of ROS by the ROS-BCL6B-NOX1 pathway. Here we report the critical role of oxygen on ROS-induced self-renewal. Cultured SSCs proliferated poorly and lacked BCL6B expression under hypoxia despite increase in mitochondria-derived ROS. Due to lack of ROS amplification under hypoxia, NOX1-derived ROS were significantly reduced, and

Indexed as

Adult Germline Stem CellsAnimalsCell DivisionCell HypoxiaCell ProliferationCells, CulturedDNA Topoisomerases, Type IGene Expression Regulation, DevelopmentalHypoxia-Inducible Factor 1, alpha SubunitMiceMice, KnockoutMitochondriaNADPH Oxidase 1OxygenReactive Oxygen SpeciesDNA Topoisomerases, Type IHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitNADPH Oxidase 1NOX1 protein, mouseOxygenReactive Oxygen SpeciesTop1mt protein, mouseHif1reactive oxygen speciesspermatogonia

Identifiers

PMID33446567
PMCPMC7849365
OpenAlexW3119847550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.